Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis

Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis

BackgroundApproximately 15% to 20% of patients will experience disease recurrence following surgical removal of renal cell carcinoma. A range of pharmacological agents is prescribed for metastatic renal cell carcinoma, but there are trials testing whether these have an earlier role in the adjuvant s...

Full description

Saved in:
Bibliographic Details
Main Authors: Niranjan J. Sathianathen, Marc A. Furrer, Christopher J. Weight, Declan G. Murphy, Shilpa Gupta, Nathan Lawrentschuk
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Société Internationale d’Urologie Journal
Subjects:
renal cancer
immunotherapy
systematic review
Online Access:https://siuj.org/index.php/siuj/article/view/206/148
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items